NCT06108869

Brief Summary

This study aims to investigate the influence of psychosocial factors on Chronic Spontaneous Urticaria (CSU). Preliminary research suggests a potential link between stress and the experience of CSU symptoms. In light of these findings, our study offers a stress management intervention for individuals diagnosed with CSU. The intervention consists of a 6-week online course designed to cultivate effective stress management techniques, referred to as 'attention-based training (ABT).' The course asks each participant to develop their own ABT practice, along with a one-hour session per week, providing techniques that participants can use to combat stressors related to their condition.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jun 2022Jul 2026

Study Start

First participant enrolled

June 1, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

October 16, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 31, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

October 31, 2023

Status Verified

October 1, 2023

Enrollment Period

3.8 years

First QC Date

October 16, 2023

Last Update Submit

October 25, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Identify Psychosocial Baseline of CSU patents attending Urticaria clinics

    Identify the incidence of abnormal stress/wellbeing scores of CSU patients attending urticarial clinics in Ireland and Scotland, using a baseline questionnaire made up of the Short Stress Overload Scale (10 questions), Five Facet Mindfulness Questionnaire (FFMQ) (39 questions), PERMA Profiler for wellbeing (23 questions), The Urticaria Control Test (4 questions) and Dermatology Life Quality Index (10 questions).

    21 months from month 8

  • Assess change in psychosocial measures of participants after completing an online 6 week ABT programme

    A psychosocial questionnaire made up of the Short Stress Overload Scale (10 questions), Five Facet Mindfulness Questionnaire (FFMQ) (39 questions), PERMA Profiler for wellbeing (23 questions), The Urticaria Control Test (4 questions) and Dermatology Life Quality Index (10 questions) will be provided to patients pre and post participation in the 6 week online ABT intervention.

    21 months from month 8

Study Arms (20)

1

EXPERIMENTAL

6 Week ABT intervention as described.

Other: ABT Online Programme

2

EXPERIMENTAL

6 Week ABT intervention as described.

Other: ABT Online Programme

3

EXPERIMENTAL

6 Week ABT intervention as described.

Other: ABT Online Programme

4

EXPERIMENTAL

6 Week ABT intervention as described.

Other: ABT Online Programme

5

EXPERIMENTAL

6 Week ABT intervention as described.

Other: ABT Online Programme

6

ACTIVE COMPARATOR

Delayed intervention group

Other: Delayed Control group

7

ACTIVE COMPARATOR

Delayed intervention group

Other: Delayed Control group

8

ACTIVE COMPARATOR

Delayed intervention group

Other: Delayed Control group

9

ACTIVE COMPARATOR

Delayed intervention group

Other: Delayed Control group

10

ACTIVE COMPARATOR

Delayed intervention group

Other: Delayed Control group

11

EXPERIMENTAL

ABT intervention as described

Other: ABT Online Programme

12

EXPERIMENTAL

ABT intervention as described

Other: ABT Online Programme

13

EXPERIMENTAL

ABT intervention as described

Other: ABT Online Programme

14

EXPERIMENTAL

ABT intervention as described

Other: ABT Online Programme

15

EXPERIMENTAL

ABT intervention as described

Other: ABT Online Programme

16

ACTIVE COMPARATOR

Delayed Control group

Other: Delayed Control group

17

ACTIVE COMPARATOR

Delayed Control group

Other: Delayed Control group

18

ACTIVE COMPARATOR

Delayed Control group

Other: Delayed Control group

19

ACTIVE COMPARATOR

Delayed Control group

Other: Delayed Control group

20

ACTIVE COMPARATOR

Delayed Control group

Other: Delayed Control group

Interventions

When the study begins, participants meet each week on Microsoft teams for a 6 week period. Each session will last approximately 1 hour. There will be a maximum of six other participants and two facilitators present at each session. Each session will consist of: * A short ABT practice * An educational component related to the development of our ABT practice * A group discussion on the week's topic and how it relates to you and your diagnosis

111121314152345

Participants will still meet as a group for first two weeks, before beginning with the ABT practice.

1016171819206789

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must have diagnosis of CSU

You may not qualify if:

  • Classified as a vulnerable adult Cannot communicate online, in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St James's Hospital

Dublin, Ireland

Location

Related Links

MeSH Terms

Conditions

Chronic Urticaria

Condition Hierarchy (Ancestors)

UrticariaSkin Diseases, VascularSkin DiseasesSkin and Connective Tissue DiseasesHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Niall Conlon, PhD

    St. James's Hospital, Ireland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Single groups will be taken through the ABT programme, or the delayed control intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2023

First Posted

October 31, 2023

Study Start

June 1, 2022

Primary Completion

April 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

October 31, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations